Find similar content

Source channel @githubtrending · Post #14682 · May 7

#kotlin#android#awt#compose#declarative_ui#desktop#gui#ios#javascript#kotlin#multiplatform#reactive#swing#ui#wasm#web#webassembly Compose Multiplatform is a Kotlin-based framework by JetBrains that lets you build user interfaces for multiple platforms—iOS, Android, desktop (Windows, macOS, Linux), and web—using mostly shared code. It is based on Jetpack Compose for Android, so you can use similar APIs across platforms, speeding up development and ensuring consistent UI design. iOS support is in beta, web is in alpha, and desktop and Android are stable. You can also access native features like camera or maps easily. This helps you save time, reduce bugs, and create apps that work well everywhere with less effort. https://github.com/JetBrains/compose-multiplatform

Hashtags

#kotlin #android #awt #compose #declarative_ui #desktop #gui #ios #javascript #multiplatform #reactive #swing #ui #wasm #web #webassembly

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment